Yasutaka Aoyama

1.1k total citations
43 papers, 294 citations indexed

About

Yasutaka Aoyama is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Yasutaka Aoyama has authored 43 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Yasutaka Aoyama's work include Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Yasutaka Aoyama is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Yasutaka Aoyama collaborates with scholars based in Japan and Germany. Yasutaka Aoyama's co-authors include Takahisa Yamane, Masayuki Hino, Hirohisa Nakamae, Kensuke Ohta, Atsuko Mugitani, Yoshiki Terada, T Takubo, Joji Nagasaki, Taro Hasegawa and Noriyuki Tatsumi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Yasutaka Aoyama

41 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutaka Aoyama Japan 11 138 80 77 46 44 43 294
Emre Tekgündüz Türkiye 10 139 1.0× 81 1.0× 45 0.6× 46 1.0× 33 0.8× 58 316
Seçkin Çağırgan Türkiye 9 187 1.4× 67 0.8× 41 0.5× 31 0.7× 56 1.3× 45 329
Ryoko Yamasaki Japan 11 166 1.2× 116 1.4× 55 0.7× 67 1.5× 40 0.9× 33 314
Holly Miller United States 9 229 1.7× 88 1.1× 140 1.8× 66 1.4× 35 0.8× 29 401
Takashi Fukuhara Japan 11 168 1.2× 39 0.5× 76 1.0× 30 0.7× 45 1.0× 40 302
Kazuo Hatanaka Japan 10 157 1.1× 77 1.0× 51 0.7× 31 0.7× 25 0.6× 33 264
Elena Tagliaferri Italy 10 94 0.7× 54 0.7× 84 1.1× 62 1.3× 22 0.5× 19 261
Young Bae Choi South Korea 11 97 0.7× 68 0.8× 35 0.5× 69 1.5× 52 1.2× 36 313
Meiqing Wu China 10 256 1.9× 134 1.7× 86 1.1× 71 1.5× 54 1.2× 40 442
K. W. Chan United States 10 262 1.9× 106 1.3× 66 0.9× 35 0.8× 23 0.5× 15 386

Countries citing papers authored by Yasutaka Aoyama

Since Specialization
Citations

This map shows the geographic impact of Yasutaka Aoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutaka Aoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutaka Aoyama more than expected).

Fields of papers citing papers by Yasutaka Aoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutaka Aoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutaka Aoyama. The network helps show where Yasutaka Aoyama may publish in the future.

Co-authorship network of co-authors of Yasutaka Aoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutaka Aoyama. A scholar is included among the top collaborators of Yasutaka Aoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutaka Aoyama. Yasutaka Aoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoyama, Yasutaka, Joji Nagasaki, Hiroshi Harada, et al.. (2017). Pulmonary Involvement of Acute Myeloid Leukemia Mimicking Transfusion-related Acute Lung Injury. Internal Medicine. 56(18). 2493–2496. 1 indexed citations
2.
Fujisawa, Shin, Shuichi Mizuta, Hideki Akiyama, et al.. (2017). Phase II study of imatinib‐based chemotherapy for newly diagnosed BCR‐ABL‐positive acute lymphoblastic leukemia. American Journal of Hematology. 92(4). 367–374. 20 indexed citations
3.
Nakane, Takahiko, Hirohisa Nakamae, Takuhiro Yamaguchi, et al.. (2016). Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials. International Journal of Hematology. 105(4). 485–496. 5 indexed citations
4.
5.
Nagasaki, Joji, et al.. (2016). Reversible dasatinib-related pulmonary arterial hypertension in a CML patient.. PubMed. 57(5). 618–23. 1 indexed citations
6.
Manabe, Masahiro, Hirofumi Nakano, Naonori Harada, et al.. (2012). Derivative (5;19)(p10;q10): A rare but recurrent whole‐arm translocation in acute myeloid leukemia. Asia-Pacific Journal of Clinical Oncology. 10(2). e122–6. 2 indexed citations
7.
Ohta, Kensuke, Yoshitaka Nakao, Erina Sakamoto, et al.. (2009). Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan. International Journal of Hematology. 89(5). 649–655. 6 indexed citations
8.
Aoyama, Yasutaka, Atsuko Mugitani, Takahisa Yamane, et al.. (2006). [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].. PubMed. 47(12). 1528–32. 2 indexed citations
9.
Hirose, Asao, Takahisa Yamane, Y. Nakajima, et al.. (2005). [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].. PubMed. 32(13). 2059–64. 1 indexed citations
10.
11.
12.
Yamane, Takahisa, Yasutaka Aoyama, Taro Hasegawa, et al.. (2003). Excretion of Granulocyte Colony-Stimulating Factor into Human Breast Milk. Acta Haematologica. 110(4). 200–201. 3 indexed citations
13.
Aoyama, Yasutaka, Masayuki Hino, Etsuko Shima, et al.. (2003). Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma. Annals of Hematology. 82(6). 371–373. 12 indexed citations
14.
Aoyama, Yasutaka, Hirohisa Nakamae, Kaori Makita, et al.. (2003). Reduced‐intensity stem cell transplantation in two cases of metastatic renal cell carcinoma. International Journal of Urology. 10(11). 610–614. 1 indexed citations
15.
Aoyama, Yasutaka, Takahisa Yamane, Masayuki Hino, et al.. (2001). Blastic NK-cell lymphoma/leukemia with T-cell receptor γ rearrangement. Annals of Hematology. 80(12). 752–754. 13 indexed citations
16.
Ohta, Kensuke, Nobuo Nagao, Masayuki Hino, et al.. (2001). Primary refractoriness to platelet transfusion caused by Naka antibody alone. Vox Sanguinis. 81(1). 42–44. 12 indexed citations
17.
Aoyama, Yasutaka, Takahisa Yamane, Masayuki Hino, et al.. (2001). Nodal Gamma/Delta T Cell Lymphoma in Complete Remission following Allogeneic Bone Marrow Transplantation from an HLA-Matched Unrelated Donor. Acta Haematologica. 105(1). 49–52. 4 indexed citations
18.
Shima, Etsuko, Masayuki Hino, Takahisa Yamane, et al.. (2001). Acute rhabdomyolysis following administration of high-dose cyclophosphamide: case report. Annals of Hematology. 81(1). 55–56. 16 indexed citations
19.
Takubo, Takayuki, Takafumi Nakao, Hirohisa Nakamae, et al.. (2000). Comparative Study on Complete Remission Rate and Overall Survival in Three Groups Classified Based on the Serum Interleukin-18 Level in Non-Hodgkin’s Lymphoma Patients. Acta Haematologica. 104(4). 220–222. 17 indexed citations
20.
Hiyoshi, Masaya, S Tagawa, Tetsuo Hasegawa, et al.. (1998). Hepatic Candidiasis Responding to a Low-dose Infusion of Amphotericin B in a Patient with Acute Leukemia. Kansenshogaku zasshi. 72(12). 1321–1324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emre Tekgündüz Breakdown of academic impact, for papers by Seçkin Çağırgan Breakdown of academic impact, for papers by Ryoko Yamasaki Breakdown of academic impact, for papers by Holly Miller Breakdown of academic impact, for papers by Takashi Fukuhara Breakdown of academic impact, for papers by Kazuo Hatanaka Breakdown of academic impact, for papers by Elena Tagliaferri Breakdown of academic impact, for papers by Young Bae Choi Breakdown of academic impact, for papers by Meiqing Wu Breakdown of academic impact, for papers by K. W. Chan
Rankless by CCL
2026